ILDR1 Gene Deafness Autosomal Recessive Type 42 Genetic Test
Are you concerned about hearing loss? DNA Labs UAE offers the ILDR1 Gene Deafness Autosomal Recessive Type 42 Genetic Test to provide valuable insights into your genetic predisposition to DFNB42.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Before undergoing the ILDR1 Gene Deafness Autosomal Recessive Type 42 Genetic Test, it is important to provide the clinical history of the patient who is going for the SLC52A2 Gene Brown-Vialetto-Van Laere Syndrome Type 2 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere Syndrome Type 2 NGS Genetic DNA Test gene SLC52A10.
Test Details
The ILDR1 gene deafness, autosomal recessive type 42 (DFNB42) is a genetic disorder that causes hearing loss. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to rapidly and accurately sequence multiple genes simultaneously. In the context of ILDR1 gene deafness, NGS genetic testing can be used to identify mutations or variations in the ILDR1 gene that may be responsible for the condition.
By analyzing the DNA sequence of the ILDR1 gene, NGS genetic testing can provide valuable information about an individual’s genetic predisposition to DFNB42. This information can help with diagnosis, genetic counseling, and potentially guide treatment options.
It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.
| Test Name | ILDR1 Gene Deafness autosomal recessive type 42 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A10 |
| Test Details |
ILDR1 gene deafness, autosomal recessive type 42 (DFNB42) is a genetic disorder that causes hearing loss. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to rapidly and accurately sequence multiple genes simultaneously. In the context of ILDR1 gene deafness, NGS genetic testing can be used to identify mutations or variations in the ILDR1 gene that may be responsible for the condition. By analyzing the DNA sequence of the ILDR1 gene, NGS genetic testing can provide valuable information about an individual’s genetic predisposition to DFNB42. This information can help with diagnosis, genetic counseling, and potentially guide treatment options. It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations based on the individual’s specific situation. |
